•
Dec 31, 2022
Precigen Q4 2022 Earnings Report
Precigen reported fourth quarter and full year 2022 financial results.
Key Takeaways
Precigen's Q4 2022 saw a decrease in total revenues by $1.9 million compared to the prior year period, alongside a reduction in research and development expenses. The company's loss from continuing operations was $22.2 million, an improvement from the previous year's $26.7 million.
Total revenues decreased by $1.9 million, or 52%, compared to Q4 2021.
Exemplar's product and service revenues decreased by $1.8 million compared to Q4 2021.
Research and development expenses decreased by $1.4 million, or 11%, compared to Q4 2021.
Loss from continuing operations was $22.2 million, or $(0.11) per basic and diluted share, compared to $26.7 million in 2021.